Objectives: 1. Describe the safety profile of droperidol in terms of torsades and QTc prolongation 2. Recall the starting dose of droperidol for agitation, migraine, and nausea in an ED population

Objectives: 1. Describe the reasons why agitated delirium might require treatment in the ICU 2. Recall the classes of medications with published data for agitated delirium in ICU patients

Objectives: 1. Describe the 5-step process for pre-rounding suggested in this training 2. Recall the FASTHUG-MAIDENS mnemonic

Objectives: 1. Describe the evidence that supports the use of ampicillin+ceftriaxone for EFIE. 2. Recall the AHA/IDSA guideline author’s position on the use of ampicillin+ceftriaxone vs ampicillin+gentamicin for EFIE.

Objectives: 1. Describe the antiplatelet strategies used in contemporary management of STEMI 2. Recall the fibrinolytic doses for STEMI reperfusion

Objectives: 1. Describe the revised stages of heart failure 2. Recall the recommendations for treatment of AFib in patients with HF

Objectives: 1. Describe the common pharmacologic interventions necessary to support a patient with ICH 2. Recall the reason why corticosteroids are not used to lower ICP

Objectives: 1. Describe the benefits of having a standard policy format 2. Recall the reason to delineate policy statements to the appropriate discipline

Objectives: 1. Describe the types of interventions that are best not discussed on rounds 2. Recall 3 examples of judgmental and non-judgmental language

Objectives: 1. Describe the typical pathogens responsible for causing orbital cellulitis 2. Recall the typical duration of antibiotic therapy for orbital cellulitis

Objectives: 1. Describe the typical presentation of CHS 2. Recall the evidence comparing haloperidol and ondansetron for CHS

Objectives: 1. Describe the reason for a loading dose of apixaban when used for VTE 2. Recall the duration of parenteral anticoagulation that was used in the FDA approval studies for apixaban to treat VTE